Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hofseth BioCare ASAOSTO:HBCO 53 Market Cap is kr679.3 Mil as of Jul. 20, 2026. GuruFocus rates OSTO:HBCO with a GF Score™ of 53/100 and a GF Value™ of kr2.29 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 2,048 Consumer Packaged Goods companies, Hofseth BioCare ASA ranks worse than 56.88% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hofseth BioCare ASA's share price for the quarter that ended in Mar. 2026 was kr1.445. Hofseth BioCare ASA's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 395.1 Mil. Therefore, Hofseth BioCare ASA's market cap for the quarter that ended in Mar. 2026 was kr570.9 Mil.
Hofseth BioCare ASA's quarterly market cap
declined
from Sep. 2025 (kr809.9 Mil) to Dec. 2025 (kr521.5 Mil) but then
increased
from Dec. 2025 (kr521.5 Mil) to Mar. 2026 (kr570.9 Mil).
Hofseth BioCare ASA's annual market cap
declined
from Dec. 2023 (kr971.9 Mil) to Dec. 2024 (kr608.4 Mil) and
declined
from Dec. 2024 (kr608.4 Mil) to Dec. 2025 (kr521.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hofseth BioCare ASA's Enterprise Value for Today is kr982.8 Mil.
Hofseth BioCare ASA (OSTO:HBCO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hofseth BioCare ASA Market Cap Related Terms
Hofseth BioCare ASA Market Cap Historical Data
* Premium members only.
The historical data trend for Hofseth BioCare ASA's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Hofseth BioCare ASA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hofseth BioCare ASA Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Hofseth BioCare ASA's Market Cap distribution charts can be found below:
* The bar in red indicates where Hofseth BioCare ASA's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Hofseth BioCare ASA's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hofseth BioCare ASA (OSTO:HBCO) has a Market Cap of kr679.3 Mil as of Jul. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hofseth BioCare ASA and its competitors. According to the industry distribution chart, Hofseth BioCare ASA ranks #1165 out of 2048 companies in the Consumer Packaged Goods industry, placing it in the top 56.9%.
Is Hofseth BioCare ASA's Market Cap too high?
Hofseth BioCare ASA's current Market Cap is kr679.3 Mil. Based on the distribution chart, Hofseth BioCare ASA ranks #1165 out of 2048 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Hofseth BioCare ASA has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hofseth BioCare ASA's Market Cap compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hofseth BioCare ASA ranks #1165 out of 2048 companies for Market Cap. This places Hofseth BioCare ASA in the lower half of its industry. The industry median Market Cap is 102.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 102.05, based on 2,048 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hofseth BioCare ASA and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 102.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hofseth BioCare ASA's current Market Cap is kr679.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hofseth BioCare ASA stock overvalued right now?
Based on GuruFocus' analysis, Hofseth BioCare ASA (OSTO:HBCO) is currently considered Possible Value Trap. The stock's GF Value™ is kr2.29, compared to a current price of kr1.45 — trading 36.7% below its estimated fair value. The current Market Cap is kr679.3 Mil. Hofseth BioCare ASA's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hofseth BioCare ASA (OSTO:HBCO), the current Market Cap is kr679.3 Mil as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hofseth BioCare ASA (OSTO:HBCO) Overvalued in 2026?
Based on GuruFocus' analysis, Hofseth BioCare ASA stock appears to be undervalued.
The current stock price of kr1.45 is trading 36.7% below its estimated GF Value™ of kr2.29.
GuruFocus considers Hofseth BioCare ASA to be Possible Value Trap.
Key valuation signals for OSTO:HBCO:
Market Cap: kr679.3 Mil
GF Value™: kr2.29 vs. price of kr1.45 (36.7% below fair value)
No single metric tells the full story. See the OSTO:HBCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
53GF Score
Get the complete analysis for OSTO:HBCO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:HBCO has been successfully added to your 
